These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27189470)

  • 21. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.
    Wei BB; Liu MY; Chen ZX; Wei MJ
    Acta Pharmacol Sin; 2018 Apr; 39(4):616-625. PubMed ID: 29323336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal plasticity during the progression of Alzheimer's disease.
    Mufson EJ; Mahady L; Waters D; Counts SE; Perez SE; DeKosky ST; Ginsberg SD; Ikonomovic MD; Scheff SW; Binder LI
    Neuroscience; 2015 Nov; 309():51-67. PubMed ID: 25772787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages.
    Serrano FG; Tapia-Rojas C; Carvajal FJ; Cisternas P; Viayna E; Sola I; Munoz-Torrero D; Inestrosa NC
    Curr Alzheimer Res; 2016; 13(9):1017-29. PubMed ID: 26502813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Andrographolide recovers cognitive impairment in a natural model of Alzheimer's disease (Octodon degus).
    Rivera DS; Lindsay C; Codocedo JF; Morel I; Pinto C; Cisternas P; Bozinovic F; Inestrosa NC
    Neurobiol Aging; 2016 Oct; 46():204-20. PubMed ID: 27505720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
    Pluta R; Ułamek-Kozioł M; Czuczwar SJ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disease, time to turn the tide.
    Sensi SL
    Aging (Albany NY); 2018 Oct; 10(10):2537-2538. PubMed ID: 30317224
    [No Abstract]   [Full Text] [Related]  

  • 30. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease?
    Fitzgerald PJ
    Curr Alzheimer Res; 2010 Sep; 7(6):506-16. PubMed ID: 20626335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial.
    Lin CH; Chen PK; Chang YC; Chuo LJ; Chen YS; Tsai GE; Lane HY
    Biol Psychiatry; 2014 May; 75(9):678-85. PubMed ID: 24074637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nootropic drugs and their action mechanisms in relation to the neuropathobiology of senile dementia. I. Neurotransmission disorders in the brain].
    Benesová O
    Cesk Psychiatr; 1994 Aug; 90(4):191-200. PubMed ID: 7987928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease.
    Dhanjal NS; Warren JE; Patel MC; Wise RJ
    Ann Neurol; 2013 Feb; 73(2):294-302. PubMed ID: 23281111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?
    Merlo S; Spampinato SF; Sortino MA
    CNS Neurosci Ther; 2019 Jan; 25(1):5-13. PubMed ID: 30101571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    Babiloni C; Del Percio C; Lizio R; Noce G; Lopez S; Soricelli A; Ferri R; Pascarelli MT; Catania V; Nobili F; Arnaldi D; Famà F; Aarsland D; Orzi F; Buttinelli C; Giubilei F; Onofrj M; Stocchi F; Vacca L; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Garn H; Fraioli L; Pievani M; Frisoni GB; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Başar E; Yener G; Emek-Savaş DD; Triggiani AI; Franciotti R; Taylor JP; De Pandis MF; Bonanni L
    J Alzheimers Dis; 2018; 62(1):247-268. PubMed ID: 29439335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noradrenergic Locus Coeruleus pathways in pain modulation.
    Llorca-Torralba M; Borges G; Neto F; Mico JA; Berrocoso E
    Neuroscience; 2016 Dec; 338():93-113. PubMed ID: 27267247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.